Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Therapeutics for Biodefense and Emerging Infectious Diseases
Henkel, Timothy
Venatorx Pharmaceuticals, Inc., Malvern, PA, United States
Search 5 grants from Timothy Henkel
Search grants from Venatorx Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Proteogenetics of Autism Spectrum Disorders
Clinical and Laboratory Research Training for Surgical Oncologists
Automated Text Messaging to Improve Depression Treatment in Low-Income Settings
Determination of Cell Fate in Development
Influence of Structure on Isopentenoid Metabolism
Recently added grants:
Characterization of the p53-CBP/p300 Transcriptional Activator-Coactivator Complex
Quantitative and Functional Proteomics Core
Determining how cell growth triggers cell division
Molecular mechanisms underlying sensory neuron regeneration and function
Cellular and Molecular Imaging Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201600029C-0-0-1
Application #
9358448
Study Section
Project Start
2016-09-23
Project End
2019-01-31
Budget Start
Budget End
Support Year
Fiscal Year
2016
Total Cost
Indirect Cost
Institution
Name
Venatorx Pharmaceuticals, Inc.
Department
Type
DUNS #
962754037
City
Malvern
State
PA
Country
United States
Zip Code
19355
Related projects
Comments
Be the first to comment on Timothy Henkel's grant
